tenk.fyi

Denali Therapeutics Inc.

DNLINasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$0

Net Income

-$512.5M

21.2% YoY

EPS

$-2.97

15.6% YoY

Cash

$205.3M

17.4% YoY

FY 2025 · As of 2025-12-31